Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes.

@article{Schmoelzer2005BiphasicIA,
  title={Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes.},
  author={Isabella Schmoelzer and A de Campo and Helga Pressl and H Stelzl and Peter Dittrich and Karl Oettl and Thomas C. Wascher},
  journal={Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association},
  year={2005},
  volume={113 3},
  pages={176-81}
}
BACKGROUND Premixed insulin analogues reduce postprandial hyperglycemia in patients with Type 2 diabetes in comparison to premixed regular insulin. Insulin also plays an important role in the regulation of postprandial lipid metabolism. It is known that increased levels of postprandial insulin reduce postprandial hyperlipemia but, on the other hand, no… CONTINUE READING